Skip to main content
rants_case-study-background-scaled-1

Our Grants

GRANT DATE AMOUNT PROGRAM
St. Mark's Hospital Foundation
Global Perianal Crohn's Disease Priority Setting Partnership
01.09.2025 $24,288.00 Crohn's Disease, Diagnostics
Crohn's & Colitis Foundation, Inc.
Achieving Remission in IBD: Optimizing Treat-to-Target in Clinical Practice
01.09.2025 $3,994,810.00 Crohn's Disease, Disease Management
Icahn School Of Medicine At Mount Sinai
The Use of GLP-1R Agonists to Promote Epithelial Healing in Crohn's Disease
11.05.2024 $3,035,566.00 Crohn's Disease, Therapeutics
Alimentiv Inc.
Validation of the PRO Symptoms and Impacts Questionnaire for Crohn's Disease
11.05.2024 $1,275,257.00 Crohn's Disease, Diagnostics
Crohn's and Colitis UK
Implementation of a Lower GI Diagnostic Pathway in Primary Healthcare and development and dissemination of a Lower GI Patient Toolkit
11.05.2024 $638,508.00 Crohn's Disease, Disease Management
Mass General Brigham for the Brigham and Women's Hospital
Real-time Post-op Touchless, Remote Monitoring in Crohn's disease: The Sapphire Trial
10.22.2024 $5,117,928.00 Crohn's Disease, Disease Management
The Chancellor, Masters and Scholars of the University of Cambridge
New insights into Crohn's disease from studying Naked Mole Rats
10.22.2024 $1,857,860.00 Crohn's Disease, Disease Biology
Mass General Brigham for the Massachusetts General Hospital
Validation of Wireless Thermal and Microscopic Imaging Technology for Quantifying Inflammation and Fibrosis in Crohn's Disease
10.22.2024 $3,057,197.00 Crohn's Disease, Diagnostics
Crohn's & Colitis Foundation, Inc.
Sponsorship for the 2025 Crohn's & Colitis Congress presented by The Crohn's & Colitis Foundation and the American Gastroenterological Association
10.22.2024 $235,000.00 Crohn's Disease, Disease Management
Katholieke Universiteit te Leuven
Targeting chronic inflammation and tissue remodelling in Crohn's disease with engineered T cells
10.22.2024 $815,615.00 Crohn's Disease, Disease Biology
Board of Trustees of the Leland Stanford Junior University
Determining the Therapeutic Potential of Statins on Stricturing Crohn's Disease
10.09.2024 $2,034,990.00 Crohn's Disease, Therapeutics
The University of Edinburgh
Building a cross-discipline scientific approach towards understanding Crohn's disease - Leveraging UK Helmsley Studies
09.24.2024 $47,977.00 Crohn's Disease, Diagnostics
The Governors of the University of Calgary
A Drug-Wide Scan to Identify Repurposed Medications for Crohn's Disease
09.24.2024 $1,248,808.00 Crohn's Disease, Therapeutics
University of Glasgow Court
Title: Unraveling the role of the gut microbiome in postoperative outcomes and disease recurrence in surgical adults with Crohn's disease treated with exclusive enteral nutrition. The MI-OCEAN study
09.10.2024 $3,187,027.00 Crohn's Disease, Prevention
The Regents of the University of Colorado, Denver
Epithelial mitochondrial dysfunction and extracellular vesicles in Crohn's disease fibrostenosis.
08.13.2024 $888,660.00 Crohn's Disease, Disease Biology
The Sheba Fund for Health Services and Research (R.A.)
The utility of hand-held ultrasound devices to detect bowel wall inflammatory activity in Crohn's disease
07.24.2024 $202,869.00 Crohn's Disease, Disease Management
Chancellor Masters & Scholars Of The University Of Oxford
Defining the signaling circuits and regulons mediating Crohn's fibrosis.
07.24.2024 $1,845,203.00 Crohn's Disease, Disease Biology
Icahn School Of Medicine At Mount Sinai
Early life exposome biomarkers and Crohn's disease risk: The EARLY-CD project
07.09.2024 $1,281,867.00 Crohn's Disease, Prevention
The Bionics Institute of Australia
Patient-specific adaptive, electric therapy for Crohn's disease
07.09.2024 $3,189,010.00 Crohn's Disease, Therapeutics
Crohn's & Colitis Foundation, Inc.
International Consortium on Medical Nutrition in IBD
07.09.2024 $310,748.00 Crohn's Disease, Prevention
You can filter rows:
Prev 12...15 Next
1 - 20 of 287 results